Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation

Cell Death and Disease

Volumn 6, Issue 4, 2015, Pages

  Simões, Aes ^a   Pereira, D M ^a   Gomes, S E ^a   Brito, H ^a   Carvalho, T ^b   French, A ^c   Castro, R E ^a   Steer, C J ^d   Thibodeau, S N ^c   Rodrigues, C M P ^a   Borralho, P M ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE 5; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL CYCLE PROGRESSION; CELL MIGRATION; CELL NUCLEUS; COLON ADENOCARCINOMA; COLON ADENOMA; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVATION; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TUMOR INVASION; ADULT; AGED; ANIMAL; CELL MOTION; COLON TUMOR; DISEASE COURSE; DRUG SCREENING; ENZYMOLOGY; FEMALE; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CELL MOVEMENT; COLONIC NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 7; NF-KAPPA B; PHOSPHORYLATION; SIGNAL TRANSDUCTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84989924728     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2015.83     Document Type: Article

References (50)

1. Siegel R. Colorectal cancer statistics2014 CA Cancer J Clin 2014; 64: 104.117.
2. Karapetis CS, Khambata-Ford S, Jonker DJ, O'Callaghan CJ, Tu D, Tebbutt NC et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med 2008; 359: 1757-1765.
3. Wolpin BM, Mayer RJ. Systemic treatment of colorectal cancer. Gastroenterology 2008; 134: 1296-1310.
4. Fang JY, Richardson BC. The MAPK signalling pathways and colorectal cancer. Lancet Oncol 2005; 6: 322-327.
5. Wang X, Tournier C. Regulation of cellular functions by the ERK5 signalling pathway. Cell Signal 2006; 18: 753-760.
6. Cude K, Wang Y, Choi HJ, Hsuan SL, Zhang H, Wang CY et al. Regulation of the G2-M cell cycle progression by the ERK5-NFkappaB signaling pathway. J Cell Biol 2007; 177: 253-264.
7. Girio A, Montero JC, Pandiella A, Chatterjee S. Erk5 is activated and acts as a survival factor in mitosis. Cell Signal 2007; 19: 1964-1972.
8. Montero JC, Ocana A, Abad M, Ortiz-Ruiz MJ, Pandiella A, Esparis-Ogando A. Expression of Erk5 in early stage breast cancer and association with disease free survival identifies this kinase as a potential therapeutic target. PLoS One 2009; 4: e5565.
9. McCracken SR, Ramsay A, Heer R, Mathers ME, Jenkins BL, Edwards J et al. Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancer. Oncogene 2008; 27: 2978-2988.
10. Sticht C, Freier K, Knopfle K, Flechtenmacher C, Pungs S, Hofele C et al. Activation of MAP kinase signaling through ERK5 but not ERK1 expression is associated with lymph node metastases in oral squamous cell carcinoma (OSCC). Neoplasia 2008; 10: 462-470.
11. Zen K, Yasui K, Nakajima T, Zen Y, Gen Y, Mitsuyoshi H et al. ERK5 is a target for gene amplification at 17p11 and promotes cell growth in hepatocellular carcinoma by regulating mitotic entry. Genes Chromosomes Cancer 2009; 48: 109-120.
12. Garaude J, Cherni S, Kaminski S, Delepine E, Chable-Bessia C, Benkirane M et al. ERK5 activates NF-kappaB in leukemic T cells and is essential for their growth in vivo. J Immunol 2006; 177: 7607-7617.
13. Hayashi M, Fearns C, Eliceiri B, Yang Y, Lee JD. Big mitogen-Activated protein kinase 1/extracellular signal-regulated kinase 5 signaling pathway is essential for tumor-Associated angiogenesis. Cancer Res 2005; 65: 7699-7706.
14. Mehta PB, Jenkins BL, McCarthy L, Thilak L, Robson CN, Neal DE et al. MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion. Oncogene 2003; 22: 1381-1389.
15. Cronan MR, Nakamura K, Johnson NL, Granger DA, Cuevas BD, Wang JG et al. Defining MAP3 kinases required for MDA-MB-231 cell tumor growth and metastasis. Oncogene 2012; 31: 3889-3900.
16. Hu B, Ren D, Su D, Lin H, Xian Z, Wan X et al. Expression of the phosphorylated MEK5 protein is associated with TNM staging of colorectal cancer. BMC Cancer 2012; 12: 127.
17. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006; 441: 431-436.
18. Li Z, Li J, Mo B, Hu C, Liu H, Qi H et al. Genistein induces cell apoptosis in MDA-MB-231 breast cancer cells via the mitogen-Activated protein kinase pathway. Toxicol In Vitro 2008; 22: 1749-1753.
19. Goalstone ML. ERK5: a novel IKKalpha-kinase in rat hippocampal neurons. Can J Neurol Sci 2011; 38: 639-648.
20. Huber MA, Azoitei N, Baumann B, Grunert S, Sommer A, Pehamberger H et al. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 2004; 114: 569-581.
21. Lilienbaum A, Paulin D. Activation of the human vimentin gene by the Tax human T-cell leukemia virus. I. Mechanisms of regulation by the NF-kappa B transcription factor. J Biol Chem 1993; 268: 2180-2188.
22. Linnerth NM, Baldwin M, Campbell C, Brown M, McGowan H, Moorehead RA. IGF-II induces CREB phosphorylation and cell survival in human lung cancer cells. Oncogene 2005; 24: 7310-7319.
23. Ramsay AK, McCracken SR, Soofi M, Fleming J, Yu AX, Ahmad I et al. ERK5 signalling in prostate cancer promotes an invasive phenotype. Br J Cancer 2011; 104: 664-672.
24. Akao Y, Nakagawa Y, Hirata I, Iio A, Itoh T, Kojima K et al. Role of anti-oncomirs miR-143 and-145 in human colorectal tumors. Cancer Gene Ther 2010; 17: 398-408.
25. Michael MZ, van Holst Pellekaan SM OC, Young NG, James GP. RJ. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003; 1: 882-891.
26. Sakamoto K, Maeda S, Hikiba Y, Nakagawa H, Hayakawa Y, Shibata W et al. Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth. Clin Cancer Res 2009; 15: 2248-2258.
27. Voboril R, Hochwald SN, Li J, Brank A,Weberova J,Wessels F et al. Inhibition of NF-kappa B augments sensitivity to 5-fluorouracil/folinic acid in colon cancer. J Surg Res 2004; 120: 178-188.
28. Yu YY, Li Q, Zhu ZG. NF-kappaB as a molecular target in adjuvant therapy of gastrointestinal carcinomas. Eur J Surg Oncol 2005; 31: 386-392.
29. Song H, Jin X, Lin J. Stat3 upregulates MEK5 expression in human breast cancer cells. Oncogene 2004; 23: 8301-8309.
30. Weldon CB, Scandurro AB, Rolfe KW, Clayton JL, Elliott S, Butler NN et al. Identification of mitogen-Activated protein kinase kinase as a chemoresistant pathway in MCF-7 cells by using gene expression microarray. Surgery 2002; 132: 293-301.
31. Pacifico F, Leonardi A. NF-kappaB in solid tumors. Biochem Pharmacol 2006; 72: 1142-1152.
32. Perez-Madrigal D, Finegan KG, Paramo B, Tournier C. The extracellular-regulated protein kinase 5 (ERK5) promotes cell proliferation through the down-regulation of inhibitors of cyclin dependent protein kinases (CDKs). Cell Signal 2012; 24: 2360-2368.
33. Kato Y, Tapping RI, Huang S, Watson MH, Ulevitch RJ, Lee JD. Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor. Nature 1998; 395: 713-716.
34. Wang X, Gocek E, Novik V, Harrison JS, Danilenko M, Studzinski GP. Inhibition of Cot1/Tlp2 oncogene in AML cells reduces ERK5 activation and up-regulates p27Kip1 concomitant with enhancement of differentiation and cell cycle arrest induced by silibinin and 1,25-dihydroxyvitamin D(3). Cell Cycle 2010; 9: 4542-4551.
35. Mulloy R, Salinas S, Philips A, Hipskind RA. Activation of cyclin D1 expression by the ERK5 cascade. Oncogene 2003; 22: 5387-5398.
36. Wang X, Merritt AJ, Seyfried J, Guo C, Papadakis ES, Finegan KG et al. Targeted deletion of mek5 causes early embryonic death and defects in the extracellular signal-regulated kinase 5/myocyte enhancer factor 2 cell survival pathway. Mol Cell Biol 2005; 25: 336-345.
37. Sohn SJ, Li D, Lee LK, Winoto A. Transcriptional regulation of tissue-specific genes by the ERK5 mitogen-Activated protein kinase. Mol Cell Biol 2005; 25: 8553-8566.
38. Ivaska J, Pallari HM, Nevo J, Eriksson JE. Novel functions of vimentin in cell adhesion, migration, and signaling. Exp Cell Res 2007; 313: 2050-2062.
39. Satelli A, Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci 2011; 68: 3033-3046.
40. Phua DC, Humbert PO, Hunziker W. Vimentin regulates scribble activity by protecting it from proteasomal degradation. Mol Biol Cell 2009; 20: 2841-2855.
41. Vuoriluoto K, Haugen H, Kiviluoto S, Mpindi JP, Nevo J, Gjerdrum C et al. Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene 2011; 30: 1436-1448.
42. Lian N, Wang W, Li L, Elefteriou F, Yang X. Vimentin inhibits ATF4-mediated osteocalcin transcription and osteoblast differentiation. J Biol Chem 2009; 284: 30518-30525.
43. Oberg AL, French AJ, Sarver AL, Subramanian S, Morlan BW, Riska SM et al. miRNA expression in colon polyps provides evidence for a multihit model of colon cancer. PLoS One 2011; 6: e20465.
44. Simoes AE, Pereira DM, Amaral JD, Nunes AF, Gomes SE, Rodrigues PM et al. Efficient recovery of proteins from multiple source samples after TRIzol((R)) or TRIzol((R))LS RNA extraction and long-term storage. BMC Genomics 2013; 14: 181.
45. Dukes C. Histological grading of rectal cancer: (section of pathology). Proc R Soc Med 1937; 30: 371-376.
46. Kehoe J, Khatri VP. Staging and prognosis of colon cancer. Surg Oncol Clin N Am 2006; 15: 129-146.
47. Doebele RC, Schulze-Hoepfner FT, Hong J, Chlenski A, Zeitlin BD, Goel K et al. A novel interplay between Epac/Rap1 and mitogen-Activated protein kinase kinase 5/extracellular signal-regulated kinase 5 (MEK5/ERK5) regulates thrombospondin to control angiogenesis. Blood 2009; 114: 4592-4600.
48. Borralho PM, Kren BT, Castro RE, da Silva IB, Steer CJ, Rodrigues CM. MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells. FEBS J 2009; 276: 6689-6700.
49. Borralho PM, Simoes AE, Gomes SE, Lima RT, Carvalho T, Ferreira DM et al. miR-143 overexpression impairs growth of human colon carcinoma xenografts in mice with induction of apoptosis and inhibition of proliferation. PLoS One 2011; 6: e23787.
50. Aranha MM, Borralho PM, Ravasco P, Moreira da Silva IB, Correia L, Fernandes A et al. NF-kappaB and apoptosis in colorectal tumourigenesis. Eur J Clin Invest 2007; 37: 416-424.